LRRC70 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.099400E-01
Normal-vs-Stage2
2.511200E-01
Normal-vs-Stage3
7.080000E-01
Normal-vs-Stage4
3.797600E-01
Stage1-vs-Stage2
2.432400E-01
Stage1-vs-Stage3
8.195400E-01
Stage1-vs-Stage4
3.539000E-01
Stage2-vs-Stage3
4.915200E-01
Stage2-vs-Stage4
9.329000E-01
Stage3-vs-Stage4
4.903600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.780400E-01
Normal-vs-AfricanAmerican
5.405000E-01
Normal-vs-Asian
4.879800E-02
Caucasian-vs-AfricanAmerican
8.772000E-01
Caucasian-vs-Asian
2.044200E-02
AfricanAmerican-vs-Asian
1.451360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.440190E-01
Normal-vs-Female
5.962400E-01
Male-vs-Female
2.106100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.346600E-01
Normal-vs-Age(41-60Yrs)
5.276000E-01
Normal-vs-Age(61-80Yrs)
2.277000E-01
Normal-vs-Age(81-100Yrs)
5.889000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.520200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.270200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.209400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.501200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.620000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.340400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.924210E-01
Normal-vs-Daily Drinker
3.562200E-01
Normal-vs-Weekly Drinker
3.391000E-01
Normal-vs-Occasional Drinker
1.321020E-01
Normal-vs-Social Drinker
4.993400E-01
Non Drinker-vs-Daily Drinker
9.182600E-01
Non Drinker-vs-Weekly Drinker
2.594800E-01
Non Drinker-vs-Occasional Drinker
5.486400E-01
Non Drinker-vs-Social Drinker
8.806600E-01
Daily Drinker-vs-Weekly Drinker
2.932200E-01
Daily Drinker-vs-Occasional Drinker
5.844200E-01
Daily Drinker-vs-Social Drinker
9.371800E-01
Weekly Drinker-vs-Occasional Drinker
5.986800E-01
Weekly Drinker-vs-Social Drinker
4.152000E-01
Occasional Drinker-vs-Social Drinker
6.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.781200E-01
Normal-vs-Grade 2
4.010000E-01
Normal-vs-Grade 3
5.341000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.035600E-01
Grade 1-vs-Grade 3
2.583200E-01
Grade 1-vs-Grade 4
3.781200E-01
Grade 2-vs-Grade 3
1.564140E-02
Grade 2-vs-Grade 4
4.010000E-01
Grade 3-vs-Grade 4
5.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.911200E-01
Normal-vs-NonDiabetic
1.805040E-01
Diabetic-vs-NonDiabetic
3.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.122800E-01
Normal-vs-NoPancreatitis
3.068600E-01
Pancreatitis-vs-NoPancreatitis
1.460320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.293800E-01
Normal-vs-N1
2.872000E-01
N0-vs-N1
8.763200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.463610E-01
Normal-vs-TP53-NonMutant
5.991600E-01
TP53-Mutant-vs-TP53-NonMutant
1.65350000003173E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
